About TRANSFORMATIVE BIOTECH, LLC
Transformative Biotech develops patented direct-to-PCR technologies that enable rapid, accurate, and affordable infectious disease diagnostics at the point of care. Their innovation removes the need for sample purification, making PCR testing more accessible and scalable.
Patented direct-to-PCR testing technologyExtraction-free nucleic acid amplificationHigh-performance amplification from raw clinical samples (swabs, saliva)Compatibility with standard PCR systemsRapid and scalable testing across platforms
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to TRANSFORMATIVE BIOTECH, LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.